# Guangzhou Yuanguji Technology Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/guangzhou-yuanguji-technology-co

- Industry: Biotechnology
- Headquarters: Guangzhou, China
- Website: www.atgatcn.com
- Total disclosed funding: $15M
- Latest round: Series B (Jul 19, 2024)
- Investors on record: 5

## About

Established in 2019 and based in Guangzhou, China, Guangzhou Yuanguji Technology Co., Ltd. is a biomedical technology company that focuses on respiratory infections. The company was granted a Class III medical device business license in April 2021. The company's founder and CEO Mr. Wei Bao graduated from Sun Yat-sen University and is also the Deputy Secretary General of Guangdong Zhong Nanshan Medical Foundation, Secretary General of the Molecular Diagnostics Special Committee of IVD and Precision Medicine Industry and Investment Alliance, and was the President of Yun Kang Group Laboratories. Dr. Yong Zhang, the company's co-founder and chief scientist, graduated from the Max Planck Institute of Biochemistry in Germany, and was the founding general director of the Shenzhen National Gene Bank and assistant president of UW-Gene. It acquired certifications such as Specialized New and Medium-sized Enterprises, and High and New Technology Enterprises. In July 2024, it closed a series B funding.

The company's main business is clinical molecular testing products include pathogenic microorganism mNGS (metagenomics next generation sequencing) detection and genetic all-exome detection. Besides the company provides respiratory infection clinical solutions for testing, products, equipment, technology, interpretation, consultation, scientific research, medicine, treatment and so on.


The company generates revenue by offering molecular diagnostic services, medical technology products, and comprehensive clinical solutions for respiratory infections.

## Funding rounds

- Series B, Jul 19, 2024 — CreditEase Wealth Management, Guangzhou Baiyun Financial Holding Group, Mingzhe Asset
- Series A, Jul 21, 2021, $15M — Dynamic Capital, Redhill Capital

## Investors

- Dynamic Capital (https://capitalatlas.ai/funds/dynamic-capital) — Series A
- Redhill Capital (https://capitalatlas.ai/funds/redhill-capital) — Series A
- CreditEase Wealth Management (https://capitalatlas.ai/funds/creditease-wealth-management) — Series B
- Guangzhou Baiyun Financial Holding Group (https://capitalatlas.ai/funds/guangzhou-baiyun-financial-holding-group) — Series B
- Mingzhe Asset (https://capitalatlas.ai/funds/mingzhe-asset) — Series B